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ABSTRACT
Menstruation drives cyclic activation of endometrial progenitor cells, tissue regeneration, and mat-
uration of stromal cells, which differentiate into specialized decidual cells prior to and during preg-
nancy. Aberrant responsiveness of human endometrial stromal cells (HESCs) to deciduogenic cues
is strongly associated with recurrent pregnancy loss (RPL), suggesting a defect in cellular matura-
tion. MeDIP-seq analysis of HESCs did not reveal gross perturbations in CpG methylation in RPL cul-
tures, although quantitative differences were observed in or near genes that are frequently
deregulated in vivo. However, RPL was associated with a marked reduction in methylation of
deﬁned CA-rich motifs located throughout the genome but enriched near telomeres. Non-CpG
methylation is a hallmark of cellular multipotency. Congruently, we demonstrate that RPL is associ-
ated with a deﬁciency in endometrial clonogenic cell populations. Loss of epigenetic stemness fea-
tures also correlated with intragenic CpG hypomethylation and reduced expression of HMGB2,
coding high mobility group protein 2. We show that knockdown of this sequence-independent
chromatin protein in HESCs promotes senescence and impairs decidualization, exempliﬁed by
blunted time-dependent secretome changes. Our ﬁndings indicate that stem cell deﬁciency and
accelerated stromal senescence limit the differentiation capacity of the endometrium and predis-
pose for pregnancy failure. STEM CELLS 2016;34:346–356
SIGNIFICANCE STATEMENT
Recurrent pregnancy loss (RPL) is a common and distressing disorder. While many risk factors
have been invoked to explain RPL, the underlying pathological pathways are not understood.
We demonstrate that RPL is strongly associated with uterine stem cell deficiency and enhanced
cellular senescence. This in turn perturbs endometrial preparation for pregnancy, a process
termed decidualization, and persistence of these defects over several conception cycles will
lead to consecutive miscarriages. Our findings open up new avenues to screen women prior to
pregnancy for the risk of miscarriage and point to the potential of cell-based therapies in the
prevention of RPL.
INTRODUCTION
Between 15% and 25% of pregnancies end in
miscarriage, deﬁned as the loss of pregnancy
before the fetus reaches viability [1]. Most
miscarriages are sporadic and occur before 12
weeks gestation. They frequently involve
numeric chromosome errors in the conceptus.
Recurrent pregnancy loss (RPL), deﬁned by
consecutive miscarriages, is viewed as a dis-
tinct disorder [2]. It is estimated that 5% of
women experience two clinical miscarriages
and approximately 1% three or more losses
[3]. In RPL, the incidence of euploidic fetal loss
increases with each additional miscarriage,
whereas the likelihood of a future successful
pregnancy gradually decreases [4, 5]. Clinically,
RPL is a debilitating disorder, associated with
considerable psychological morbidity, for which
there is no effective medical intervention. For-
tunately, the cumulative live birth rate for
most RPL patients is high [1, 4, 5], which in
turn suggests that embryo-endometrial interac-
tions are intrinsically dynamic and capable of
adapting to ensure reproductive success [6].
Human embryos are exceptionally diverse
in their chromosomal make-up and develop-
mental potential [7, 8]. Recent studies have
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shown that decidualizing (differentiating) endometrial stromal
cells serve as biosensors of embryos that have breached the
luminal epithelium [9, 10]. This observation led to the concept
of “natural selection,” meaning that decidualizing endome-
trium responds to embryonic signals in a manner that either
supports further development or leads to rapid demise
through menstruation-like shedding; thus increasing the likeli-
hood of future reproductive success by safeguarding resources
and expediting recovery. Emerging evidence indicates that
abnormal decidualization causes loss of the selectivity check-
point, which renders the endometrium excessively permissive
to implantation but unable to sustain the conceptus [11, 12].
This hypothesis is supported by in vitro studies demonstrating
that RPL is associated with aberrant responsiveness of human
endometrial stromal cells (HESCs) to deciduogenic signals,
although the underlying mechanisms are unknown [13–15].
Decidual transformation of the human endometrium is
not dependent on embryo implantation. Instead, this process
is initiated during the mid-luteal phase of each cycle in
response to the postovulatory rise in progesterone and
increasing endometrial cAMP levels [11]. Consequently,
decidualization is a reiterative process directly linked to cyclic
activation of mesenchymal stem cells (MSCs) and subsequent
differentiation into mature stromal cells in regenerating endo-
metrium. We hypothesized that defects in cyclic regeneration
of the endometrium in RPL patients impact on the DNA meth-
ylation status of HESCs, thus accounting for the aberrant
decidual response as well as the functional memory of the
cells in culture. Based on an unbiased analysis of the DNA
methylome of primary HESC cultures, we demonstrate that
the endometrium associated with RPL exhibits loss of plastic-
ity, deﬁned by stem cell deﬁciency, heightened senescence,
and limited differentiation potential.
MATERIALS AND METHODS
Patient Selection and Endometrial Sampling
The study was approved by the NHS National Research
Ethics—Hammersmith and Queen Charlotte’s & Chelsea
Research Ethics Committee (1997/5065). For the MeDIP-seq
analysis, eight endometrial biopsies were obtained randomly
in the cycle. All other biopsies were timed between 6 and 10
days after the preovulatory luteinizing hormone surge. None
of the subjects were on hormonal treatments for at least 3
months prior to the procedure. Written informed consent was
obtained from all participants in accordance with the guide-
lines in The Declaration of Helsinki 2000. A total of 183 endo-
metrial biopsies were used in this study. Demographic details
are summarized in Supporting Information Table S1.
Primary Cultures
HESCs were isolated from endometrial tissues as described
previously [16]. Puriﬁed HESCs were expanded in maintenance
medium of Dulbecco’s modiﬁed Eagle’s medium (DMEM)/F-12
containing 10% dextran-coated charcoal-treated fetal bovine
serum (DCC-FBS), L-glutamine (1%), and 1% antibiotic-
antimycotic solution. Conﬂuent monolayers were decidualized
in DMEM/F-12 containing 2% DCC-FBS with 0.5 mM 8-bromo-
cAMP (Sigma-Aldrich, Poole, U.K., http://www.sigmaaldrich.
com) and 10 mM medroxyprogesterone acetate (Sigma-
Aldrich) to induce a differentiated phenotype. Isolation of iso-
lated W5C51- and W5C52-cells and colony-forming assays
were performed as described previously [17].
Transfection and RNA Interference
Primary HESCs were transfected in complete media at approxi-
mately 80% conﬂuence using JetPrime Reagent (Polyplus-transfec-
tion SA, Illkirch, France, http://www.polyplus-transfection.com/)
and either SMARTpool targeting small interfering RNA (siRNA)
(50 nM; GE Healthcare, Little Chalfont, U.K., http://dharmacon.ge-
lifesciences.com/) or nontargeting (NT) control. Culture media
was changed after 24 hours. For high mobility group protein 2
(HMGB2) knockdown studies, transfected cells were either main-
tained undifferentiated or decidualized for 8 days as described
above. For DNMT3A knockdown studies, cells were harvested at
24 hours after transfection and subjected to matrix-MeDIP-qPCR
analysis.
RNA Sequencing
For RNA sequencing, RNA was treated with Ampliﬁcation
grade DNase I (Life Technologies, Rockville, MD, http://www.
lifetech.com), followed by ethanol precipitation and clean-up
according to standard protocols. RNA sequencing was per-
formed by Source Bioscience (Nottingham, U.K., http://
www.lifesciences.sourcebioscience.com/) using TruSeq
Stranded mRNA Library Preparation and standard Illumina
Protocols for sequencing on HiSeq 2000. RNA integrity num-
ber for all samples was 8.2. Transcriptomic maps of single-
end reads were generated using bowtie-2.2.3, samtools-
0.1.19, and tophat-2.0.12 against the University of California
Santa Cruz (UCSC) hg19 reference transcriptome (2014) from
the Illumina iGenomes resource using the fr-ﬁrststrand set-
ting. Transcript counts were assessed by HTSeq-0.6.1 using
the reverse strand setting and intersection-non-empty mode
and counts were assigned to gene IDs. Transcripts per million
were calculated as recently described [18]. Count data from
the TopHat-HTSeq pipeline were analyzed using three different
methods for differential expression detection, that is, DESeq2,
baySeq, and edgeR [19–22]. Expression data have been sub-
mitted to the GEO repository (GSE65102).
MeDIP-seq and CpG Methylation Analysis
MeDIP-seq was performed by Arraystar (Rockville, MD
www.arraystar.com). Brieﬂy, DNA was fragmented to 100–500
bp fragments by sonication using a Bioruptor (Diagenode,
Seraing, Belgium https://www.diagenode.com/). One mg DNA
was used for end repair and adapter ligation and then immu-
noprecipitated with an anti-5-methylcytosine antibody (Diage-
node). After polymerase chain reaction (PCR) ampliﬁcation for
enrichment of precipitated fragments, 200–300 bp DNA frag-
ments were gel-extracted and quantitated using Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, http://
www.agilent.com). Libraries were denatured and sequenced
on the Genome Analyzer IIx following the TruSeq SBS Kit v5
protocol. Image analysis and base calling were performed
using Off-Line Basecaller software (OLB V1.8). After passing
the Solexa CHASTITY quality ﬁlter, clean reads were aligned to
the Human genome (UCSC Hg19) using bowtie software
(V0.12.7). Approximately, 94 million uniquely mapped reads,
representing >3.3 billion bases, were obtained for each sam-
ple. Each read was extended to 200 bp in length. A
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methylation score for any region in the genome was deﬁned
as the number of extended reads per kb [23]. The DNA meth-
ylation status of a speciﬁc region (e.g., promoter or gene
body) was deﬁned as unmethylated, partially, or fully methyl-
ated if the MeDIP score was <4.25 reads per kb, between
4.25 and 18.28 reads per kb, or >18.28 reads per kb, respec-
tively. The MeDIP-seq data were deposited to the GEO reposi-
tory (GSE65102).
MeDIP-seq Peak Characteristics and Scatter Plots
Gene body locations are as deﬁned in the UCSC hg18-based
deﬁnitions provided as part of CisGenome. Gene promoters
were taken as the ﬁrst 500 bp upstream of the gene start
position. CA/TG, Alu, and L-1 regions are as annotated in the
UCSC hg18 genome data. All regions less than 100 nt in
length were ignored as were all regions with fewer than 20
fragments in any of the samples used. Fragments were
counted if they overlapped the annotated region. The counts
are normalized to compensate for differences in total counts
between each of the samples and also the variation in region
length. Overall methylation values for a sample group
(patients, controls) are the geometric mean of the values
from each of the samples.
Analysis of Hypomethylation of CA-Rich Regions
Initial examination of the MeDIPseq data showed sample 6 to
be an outlier in terms of methylation levels in CA-rich regions.
Consequently, control sample methylation was calculated
from samples 1–4 and RPL methylation from samples 5, 7,
and 8. Figure 2B shows that a subset of annotated CA-rich
regions was hypomethylated, with most of such regions
exceeding a fold-change threshold of 1.5 (with a 1.5 fold-
change dividing the region between red and grey lines in Fig.
2B into equal halves). To expand analyses to all such regions
Figure 1. Differential CpG methylation in primary human endometrial stromal cells (HESCs) and altered endometrial gene expression
associated with RPL. (A): Comparison of average MeDIP-seq scores, reﬂecting absolute levels of CpG methylation per kb (read counts
per kb), of primary HESC cultures established from RPL patients (n5 4) and control subjects (n5 4). Overall methylation at CGIs
(slope5 0.977), promoter regions (slope5 0.986), and within gene bodies (slope5 0.996) was comparable between the sample sets.
(B): Principle component analysis of RNA-seq data from 20 mid-luteal whole endometrial biopsies segregates samples into cluster 1,
enriched in non-RPL samples (control, C); and cluster 2, encompassing 7 out of 10 biopsies obtained from miscarriage patients (M). (C):
A proportional Venn diagram of differentially expressed transcripts identiﬁed by DESeq2, baySeq, and edgeR analyses. (D): Clustered
heatmap of top-ranked transcripts differentially expressed between clusters 1 and 2. Abbreviation: RPL, recurrent pregnancy loss.
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in the genome, we scanned the genome for all loci that show-
ing 50% or more reduction in methylation in RPL compared
to control subjects and used this set of 2741 differentially
methylated regions (DMRs) in subsequent analyses.
Motif Modeling of CA-Rich DMRs
Differentially methylated peaks were ordered by methylation
ratio, deﬁned as the ratio of methylation scores between con-
trol and RPL (with exclusion of sample 6), without application
of a count or length threshold but with addition of a pseudo
count of 10 to all of the densities prior to ratio calculation to
avoid assigning signiﬁcance to peaks where the total fragment
counts are low. The Gibbs Motif Mapper, implemented in
CisGenome [24], was used to identify over-represented motifs
based on the sequences of the top 200 DMRs, searching for
10 motifs of length 20 with a background genome model
determined by a Markov model of order 0, with modiﬁcation
to allow the inclusion of repeat-masked data. CisGenome
Motif Mapping was then used to identify those locations in
the genome where there was a match between the sequence
and each of the motifs, setting the likelihood threshold to
10,000, including repetitive regions and using a background
model estimated from the input sequences with a Markov
model of order 0. The degree to which motif matches were
over-represented within the top 2,741 DMRs was found to be
between a factor of 7 and 240. DMRs were predicted solely
on the basis of the DNA sequence. At each nucleotide loca-
tion a cumulative log likelihood of all the motif matches that
overlap the location was calculated, and a candidate DMR
was identiﬁed wherever this value exceeded 60 for a mini-
mum length of 250 nt, allowing the value to drop below this
value for lengths of up to 120 nt within the region. The model
parameters were learned using a subset of the data, using
the remaining data to conﬁrm that overﬁtting did not occur.
A score equal to the cumulative value across the region is
assigned to the region. A total of 2,419 candidate DMRs were
found. To compare the motif-based method of DMR predic-
tion with prediction using simple CA/TG repeat annotation a
second set of motif-based region predictions were calculated
with a lower threshold of 10 and a reduced length threshold
of 120 nt. The genome was divided into 2 kb windows and
two scores calculated for each window: a cumulative score of
all the annotated CA regions within the window and the sec-
ond using the motif-based DMR prediction scores. The differ-
ential methylation score was calculated for each window
based on the ratio of the geometric means of the normalized
MeDIP fragments for the control and RPL samples.
Matrix-MeDIP
RNA-free DNA was fragmented using a Bioruptor (Diagnode)
over 12 low-power on (30 seconds) and off (90 seconds)
cycles. Sonication was performed in Tris-EDTA (TE) buffer, pH
8.0 at a concentration of 2 mg DNA in 100 ml TE. After sonica-
tion, DNA was ethanol precipitated and resuspended in 20 ml
elution buffer (1% SDS and 100 mm NaHCO3) and boiled at
1008C for 10 minutes. Denatured DNA was chilled on ice and
stored at 2808C. Matrix-MeDIP (microplate-based methylated
DNA immunoprecipitation) was performed as described [16].
Brieﬂy, polystyrene 96-well plates were UV exposed for 48
hours and then coated with protein A (0.5 mg per well;
Sigma-Aldrich) in phosphate buffered saline (PBS). Sonicated
DNA was immunoprecipitated with anti-5-methylcytosine anti-
body (1 mg per mg DNA; Cambridge Bioscience, Cambridge,
U.K., www.bioscience.co.uk/) at 48C for 1 hour in a sonicating
water bath. Mouse IgG1 was used as an isotype control (Cell
Signaling Technology, Beverly, MA, http://www.cellsignal.com).
During this time, protein A coated wells were washed in PBS
and blocked with 5% bovine serum albumin (BSA) in immuno-
precipitation (IP) buffer for 1 hour at room temperature (RT).
Blocking solution was aspirated, IP reactions were added to
Figure 2. RPL is associated with loss of methylation at distinct
CA-rich genomic loci. (A): Example of differential methylation
between control and RPL cultures (top panel) at a CA-rich region
on chromosome 6. A divergent pattern of methylation was not
observed at other repetitive genomic elements (bottom panel).
Loss of methylation at CA repeats was observed in all but one
RPL culture (biopsy 6, Table E1), which was excluded from further
analyses. (B): Average methylation at annotated CA-rich loci
(black dots) in control versus RPL cultures. For comparison, CpG
methylation in gene bodies (red dots) is also shown. (C): Genomic
sequences identiﬁed based on motifs are more predictive for dif-
ferential methylation than CA-richness alone. x-axis shows the
rank n of loci when sorted by motif-model score (black curve) or
CA-richness (red curve). y-Axis shows the fraction of DMRs
included in the top n loci. For example, the red cross indicates
that 41% of DMRs are included in the top 0.5% of the regions
detected by the motif model, while the remaining 59% of the
DMRs are in the other 99.5% of the genome. (D): Top 10 motifs
predictive of differentially methylated CA-rich regions. (E): The
motif model can meaningfully predict the extent of differential
methylation. x-Axis shows the predicted methylation ratio and y-
axis shows the measured methylation ratio. Each DMR is repre-
sented by a single dot. Abbreviations: DMR, differentially methyl-
ated region; RPL, recurrent pregnancy loss.
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wells and the plates then placed on ice for 1 hour. Wells were
washed four times in IP buffer and once in TE, pH 7.6, before
addition of elution buffer. DNA was eluted by incubation at
558C for 30 minutes and then at 958C 15 minutes in a thermal
cycler. Eluted DNA was subjected to real-time quantitative
PCR. Brieﬂy, reactions were prepared using 23 Power SYBR
master mix (Life Technologies), 300 nM primer, and 2 ml
eluted DNA in a 20 ml ﬁnal reaction volume. Thermal cycling
was performed with 10 min activation at 958C and 45 cycles
of 958C for 15 seconds then 608C for 1 minute. Reaction spec-
iﬁcity was conﬁrmed by dissociation curve analysis. Primer
efﬁciencies (E) were calculated from 7 log standard curves.
Relative enrichment of methylated targets was calculated as
E(Ctinput2 CtMeDIP) 3 X, where X represents the percentage
of DNA in the input versus MeDIP wells. For multiplate stud-
ies, a calibrator sample (constant) was included on all plates.
Enrichment values are expressed normalized to the IgG1 con-
trol (IgG15 1). Real-time PCR examination of known hyper-
methylated (BRD1) and hypomethylated (COQ3) control
regions conﬁrmed sensitive and speciﬁc enrichment of meth-
ylated DNA by the matrix-MeDIP approach (Supporting Infor-
mation Fig. S1). Primer sequences are detailed in Supporting
Information Table S2.
Western Blotting
Whole cell protein extracts were prepared from transfected
cells in RIPA buffer containing protease inhibitors (complete
Mini; Roche Diagnostics, Basel, Switzerland, http://www.
roche-applied-science.com). Protein yield was determined
using the BioRad Protein Assay Dye Reagent Concentrate
(BioRad, Hemel Hempstead, U.K., http://www.bio-rad.com).
Proteins were loaded equally and separated by SDS-PAGE and
transferred to polyvinylidene diﬂuoride membrane (PVDF).
Membranes were probed overnight at 48C with antibody
against HMGB2 (1:1,000; ab67282, Abcam, Cambridge, U.K.,
http://www.abcam.com) or for 1 hour at RT with antibody
against b-Actin (1:100,000; A1978, Sigma-Aldrich), followed by
incubation with horseradish peroxidase (HRP)-conjugated anti-
rabbit or anti-mouse secondary antibodies (P0448 and P0447,
respectively; Dako, Ely, U.K., http://www.dako.com). Chemilu-
minescent detection was performed using ECL Prime (GE
Healthcare), and membranes were imaged on a G:Box Chemi
XX6 (Syngene, www.syngene.com/).
Immunohistochemistry, Immunofluorescence,
and SA-b-GAL Staining
See Supporting Information Methods.
Secretome Analysis
Conditioned medium was collected from cells transfected with
either HMGB2 or NT siRNA, which either remained undifferen-
tiated or were decidualized for 2, 4, or 8 days. Undiluted con-
ditioned medium was assayed for 18 cytokines, chemokines,
and growth factors using a multiplex suspension bead immu-
noassay (Bio-Rad) according to the manufacturer’s instruc-
tions. Data analysis was carried out using ﬁve-parameter
logistic regression modeling on the Bio-Plex system [17].
Reverse Transcriptase Quantitative PCR
Reverse transcriptase quantitative PCR (RT-qPCR) was per-
formed on an Applied Biosystems 7500 system with SDS 1.4
software. For transcript analysis, RNA was extracted from cul-
tured cells using RNA STAT-60 (AMS Biotechnology, Oxford,
U.K., www.amsbio.co.uk/), according to the manufacturer’s
protocol. Puriﬁed RNA was solubilized in nuclease-free water
and quantitated using the Nanodrop ND-1000 spectrophotom-
eter. For qPCR analysis, 1 mg RNA was reverse transcribed
using the Quantitect Reverse Transcription Kit (Qiagen, Hilden,
Germany, http://www1.qiagen.com), which includes a gDNA
removal step, using a combined random hexamer and oligo
dT priming strategy. Reactions were diluted ﬁvefold to give an
equivalent of 10 ng RNA per ml and stored at 2208C. Intron-
spanning primers were used and primer sequences are tabu-
lated in Supporting Information Table S2. In addition, HMGB2
transcript levels in midluteal endometrial biopsies were meas-
ured using nCounter Gene Expression analysis (nanoString
Technologies, Seattle, www.nanostring.com/).
Cell Cycle and Proliferation Analyses
For cell cycle analysis, HESCs in suspension were washed with
PBS then ﬁxed with cold 70% ethanol, treated with RNase A
(Qiagen), stained with propidium iodide (Sigma-Aldrich) and
subjected to ﬂow cytometry analysis. Cell cycle distribution
was assessed using FlowJo software. Real-time adherent cell
proliferation was determined by the label-free xCELLigence
Real-Time Cell Analyser (RTCA) DP instrument (Roche Diagnos-
tics GmbH). Changes in cell index were captured and analyzed
using the RTCA Software v1.2.
Statistical Analysis
Statistical analyses were performed with IBM SPSS version 21
and Graphpad Prism (Graphpad Software, www.graphpad.com/).
Distribution normality and equality of variance between groups
were examined using the Kolmogorov-Smirnov and Levene’s
tests, respectively. Where these tests reported signiﬁcant differ-
ences, nonparametric tests were used for downstream compari-
sons between groups. The histogram presenting distribution
of DMRs across the genome was prepared in MATLAB using a
2.5 Mbp window. Sequence logos for over-represented motifs
were generated using the Berkeley WebLogo tool [25]. The
hypergeometric test for overlap of MeDIP-seq and RNA-seq
results was calculated using the expression phyper (80,7678,
17691,209,lower.tail5FALSE) in R.
RESULTS
Differential CpG Methylation in HESCs in RPL Patients
To investigate the DNA methylome of HESCs, we performed
MeDIP-seq, which involves IP of DNA with a 5-methylcytosine
antibody followed by deep sequencing, on primary cultures
(passage 1) established from four RPL patients and four con-
trol subjects (Supporting Information Table S1). Of the 28 mil-
lion CpGs in the haploid human genome, MeDIP-seq covered
approximately 87% at 100–300 bp resolution. The overall pat-
tern of methylation, whether at CpG islands, promoters or
gene bodies, was similar in both sample sets (Fig. 1A). Analy-
sis of MeDIP-scores, reﬂecting absolute levels of CpG methyla-
tion per kb, identiﬁed divergent methylation (2-fold; t test:
p< .01) at 209 loci, of which 48.3% and 51.7% were hypome-
thylated and hypermethylated, respectively, in RPL cultures.
The differences were, however, no longer statistically
350 MSC Deficiency in Recurrent Miscarriage
VC 2015 The Authors. STEM CELLS Published by Wiley Periodicals, Inc. on behalf of AlphaMed Press STEM CELLS
signiﬁcant following Bonferroni correction for multiple com-
parisons, questioning the pathological relevance of differential
methylation in RPL.
To address these concerns, we sequenced the transcrip-
tomes of mid-luteal endometrial biopsies from 10 RPL
patients and 10 subfertile women with no history of RPL
(Supporting Information Table S1). Principal component analy-
sis segregated the samples into two distinct clusters: a diffuse
group (cluster 1) containing 3 RPL and 7 non-RPL samples,
and a focused cluster of 10 samples, which included 7 RPL
biopsies (cluster 2) (Fig. 1B). This distribution was not
accounted for by patient demographics or by the day of the
biopsy in the cycle (Supporting Information Table S1) but
commensurate with clinical complexity as non-RPL patients
formed a heterogeneous group and not all cases of RPL can
be attributed to uterine factors. By combining baySeq,
DEseq2, and edgeR analyses, we generated a robust list of
3,214 differentially expressed genes (Fig. 1C), depicted with a
heatmap of the Z-scores of transcripts per million values in
Figure 1D. Gene ontology (GO) analysis showed enrichment of
differentially expressed genes in numerous biological catego-
ries, including response to stress (GO: 0006950; p5 4.9239),
cell death (GO: 0008219; p5 3.2221), hemostasis (GO:
0007599; p5 2.1227), wound healing (GO: 0042060;
p5 2.1224), immune response (GO: 0006955; p5 5.9228), and
leukocyte migration (GO: 0050900; p5 1.1226). The latter was
validated by immunohistochemistry, which demonstrated
higher levels of CD561 uterine natural killer cells in cluster 2
samples in keeping with enhanced levels of NCAM1 mRNA
(coding neural cell adhesion molecule 1 or CD56) (Supporting
Information Fig. S2).
Of the 209 DMRs, 80 (39%) encompassed putative regula-
tory regions of endometrial genes deregulated in cluster 2.
This group included several genes that encode for factors rel-
evant to tissue regeneration, for example insulin-like growth
factor 1 (IGF1), protection of telomeres protein 1 (POT1), and
HMGB2 (Supporting Information Fig. S3). Hypergeometric test-
ing showed a signiﬁcant overlap between the MeDIP- and
RNA-seq datasets (p5 .005), suggesting that altered CpG
methylation in HESCs may contribute to endometrial dysfunc-
tion associated with RPL. It is, however, not possible to draw
ﬁrm conclusions as multiple cell types besides HESCs, includ-
ing epithelial, immune and vascular cells, will contribute to
altered gene expression in vivo.
Loss of Methylation at CA-Rich Motifs in RPL
Standard pipelines for MeDIP-seq data a priori assume that
methylation is conﬁned to CpG dinucleotides [26]. We devel-
oped a method that removes this assumption from the analy-
sis. This unbiased approach unexpectedly uncovered 2,741
additional DMRs that were hypomethylated (>1.5-fold) in
three out of four RPL cultures (Fig. 2A, 2B). The DMRs over-
whelmingly mapped to CA-rich regions largely devoid of CpG
dinucleotides, many clustering within 15 Mb of the telomeres
(Supporting Information Fig. S4). We explored if these DMRs
were distinct merely because of CA-richness or whether they
harbored additional genomic features. A subset of the data
was used to train a motif-based model, which was then
applied on the remaining data. Both the motif-based model
and the CA-richness criterion achieved very low false positive
rates (0.004%), enabling genome-wide application. The
motif-based model outperformed the CA-richness criterion
indicating that it characterizes DMRs more accurately (Fig.
2C). As shown in Figure 2D, the 10 most signiﬁcant motifs are
characterized by varying periodicities of short k-mer repeti-
tiveness, accompanied by a periodicity of the conservation
per base pair across these loci. In addition, the statistical
scores associated with each locus strongly correlated with the
fold-change in methylation between the RPL and control sam-
ples (p< 10290; Fig. 2E). The DMRs were mostly associated
with intergenic DNA regions and introns. A survey of publi-
cally available chromatin immunoprecipitated-seq data
revealed that these CA-rich regions are relatively depleted in
transcription factor binding, although there were notable
exceptions, such as KAISO (ZBTB33, a component of the N-
CoR repression complex [27]) and the orphan nuclear recep-
tor TR4 (NR2C2) (Supporting Information Table S3). GO analy-
sis of nearest genes yielded only a single term (ion channel
activity) enriched (q value5 0.048) in the “Function” category.
Taken together, our unbiased analysis revealed a conspicu-
ous lack of methylation at distinct motifs embedded within
CA-rich regions across the HESC genome in RPL cultures.
Notably, reanalysis of published MeDIP-seq data indicated
that methylation changes in overlapping CA-rich regions are
relevant to other pathologies, including transformation of nor-
mal Schwann cells into benign and malignant peripheral nerve
sheath tumors (Supporting Information Fig. S5) [28]. The mag-
nitude of this differential epigenetic signal is large, more so in
tumors than in HESCs, and missed by standard data analysis.
Endometrial Stem Cell Deficiency and RPL
CpH (H5A/C/T) methylation is a feature of stem cells, includ-
ing embryonic stem cells and induced pluripotent stem cells,
but lost in most somatic tissues [29–32]. Modiﬁcation of cyto-
sines at CpHs is largely dependent on the de novo DNA meth-
yltransferase, DNMT3A [33]. Analysis of independent primary
cultures showed that DNMT3A mRNA levels increase in
decidualizing cells from control subjects but not RPL patients
(Fig. 3A). Matrix-MeDIP-qPCR, that is, microplate-based meth-
ylated DNA immunoprecipitation followed by qPCR [16], dem-
onstrated that DNMT3A knockdown in primary HESCs reduces
methylation of informative CA-rich but not CpG loci (Fig. 3B,
3C). The loss of an epigenetic signature associated with stem-
ness pointed toward endometrial MSC deﬁciency in RPL
patients. To investigate this further, we used an antibody
directed against type 1 integral membrane protein Sushi
domain containing 2 (also known as W5C5) to isolate perivas-
cular (W5C51) and nonperivascular (W5C52) HESCs from
timed mid-luteal biopsies [17, 34]. Analysis of 59 samples
showed no difference in the abundance of W5C51 perivascu-
lar cells between RPL and control subjects (Fig. 3D). However,
the clonogenicity of W5C51 and W5C52 cell populations was
signiﬁcantly reduced in RPL (p5 .002 and p5 .0005, respec-
tively; Fig. 3E, 3F). Strikingly, no clonogenic W5C52 cells were
recovered from 13 out of 31 (42%) RPL samples compared to
3 out of 28 (11%) control samples. Furthermore, the abun-
dance of clonogenic W5C51 or W5C52 cells correlated nega-
tively with the number of previous miscarriages (Fig. 3G, 3H).
Matrix-MeDIP-qPCR analysis revealed a similar inverse correla-
tion between the level of methylation of a randomly selected
CA-rich region (chromosome 6) and severity of the RPL phe-
notype (Fig. 3I).
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Loss of HMGB2 Impairs Decidual Transformation
of HESCs
We also interrogated putative differentially methylated CpG
loci in the expanded cohort of primary cultures. Intriguingly,
methylation levels at CA-rich loci correlated with those in the
HMGB2 gene body (p5 .001; Fig. 4A). By contrast, no associa-
tions were found with methylation of the promoter regions of
IGF1 or POT1 (Supporting Information Fig. S6). The impact of
DMRs on gene expression is difﬁcult to ascertain, although
intragenic methylation tends to enhance transcriptional elon-
gation [23, 35]. Indeed, hypomethylation of HMGB2 gene
body was associated with lower expression in cluster 2 sam-
ples (Supporting Information Fig. S3). Reduced endometrial
HMGB2 expression in RPL patients was further validated in 32
mid-luteal biopsies as well as 10 primary HESC cultures (Sup-
porting Information Fig. S7). Loss of HMGB2 is reportedly a
hallmark of replicative senescence in human ﬁbroblasts and
associated with inﬂammation, especially in aging tissues
[36–38]. To assess the functional consequences of impaired
HMGB2 expression in endometrial cells, primary cultures from
control subjects were transfected with either NT or HMGB2
siRNA (Fig. 4B). HMGB2 knockdown greatly impaired the
Figure 3. RPL is associated with a deﬁciency in endometrial clonogenic cell populations. (A): DNMT3A is induced in decidualizing pri-
mary human endometrial stromal cell (HESC) cultures from control subjects but not RPL patients. Conﬂuent primary cultures were
decidualized using 8-bromo-cAMP and medroxyprogesterone acetate for the indicated time points. Data represent mean6 SEM of ﬁve
RPL and ﬁve control cultures. Different letters above the error bars indicate that those groups are signiﬁcantly different from each other
at p< .05. (B): siRNA-mediated knockdown of DNMT3A did not impact on transcript levels of other DNA methyltransferases or high
mobility group protein 2 (HMGB2). The data show the level of expression (mean6 SEM) upon DNMT3A knockdown relative to transfec-
tion of cells with nontargeting siRNA (dotted line) in three HESC cultures. (C): Matrix-MeDIP coupled to quantitative polymerase chain
reaction (qPCR) analysis of parallel cultures shows that DNMT3A knockdown modestly but consistently reduces methylation of randomly
chosen CA-rich loci on the indicated chromosomes. The level of methylation in HMGB2 gene body was unaltered upon DNMT3A knock-
down. (D): Magnetic-activated cell sorting was used to isolate perivascular (W5C51) and nonperivascular (W5C52) endometrial stromal
cells from mid-luteal endometrial biopsies. The relative (%) abundance of W5C51-cells did not differ between biopsies obtained from
RPL (n5 34) and control subjects (n5 25) (p> .05). (E): Colony-forming assays were used to assess clonogenicity, deﬁned by the relative
abundance of % CFU of freshly isolated W5C51-cells in RPL and control biopsies. **, p5 .002. (F): In parallel, colony-forming assays
were performed on freshly isolated W5C52-cells. ***, p5 .0005. (G): Spearman’s rank was used to assess the relationship between the
number of previous pregnancy losses and clonogenicity of W5C51-cells (H) and W5C52-cells. (I): Matrix-MeDIP-qPCR analysis of 24 addi-
tional primary HESC cultures shows a negative correlation between the level of methylation at an informative CA-rich region on chromo-
some 6 and the number of previous pregnancy losses. Abbreviations: CFU, colony forming unit; DNMT, DNA methyltransferase; RPL,
recurrent pregnancy loss.
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colony-forming unit-ﬁbroblast activity of primary HESC cul-
tures (Fig. 4C). Flow cytometry analysis of three independent
primary cultures revealed accumulation of HESCs in G0/G1
phase of the cycle following transfection with HMGB2 siRNA,
which was accompanied by a reduction of cells in G2/M
phase (Fig. 4D). Real-time monitoring of cell growth more
than 100 hours using microelectronic sensor technology (xCEL-
Ligence) conﬁrmed that siRNA-mediated HMGB2 knockdown
compromises the proliferative potential of HESCs (Fig. 4E). In
parallel with loss of the proliferation antigen Ki-67, knock-
down of this chromatin protein also upregulated gamma-
H2AX phosphorylation (pH2AX) (Fig. 4F; Supporting Informa-
tion Fig S8) and induced senescence-associated b-galactosi-
dase activity (Fig. 4E). Notably, knockdown of HMGB2 was not
Figure 4. Loss of HMGB2 promotes senescence in human endometrial stromal cells (HESCs). (A): Matrix-MeDIP-qPCR analysis of 24 pri-
mary HESC cultures revealed a positive correlation between the level of intragenic HMGB2 methylation and the methylation status of
an informative CA-rich region (chromosome 6) (rs5 0.6304; p5 .001). (B): Knockdown of HMGB2 at mRNA (upper panel) and protein
level (lower panel) in response to transfection of primary HESCs with targeted versus NT siRNA. The results show the relative level of
HMGB2 knockdown in four primary cultures. Data represent mean6 SEM; ***, p< .0001., p < .0001. (C): Colony forming assays of pri-
mary cultures ﬁrst transfected with either NT or HMGB2 siRNA. The right panel shows the total colony area as measured by ImageJ anal-
ysis of three independent cultures. The data represent mean colony area (6SEM). ***, p< .001. (D): Flow cytometry analysis of
propidium iodide stained primary cultures (n5 3) shows that HMGB2 knockdown triggers accumulation of cells at G1/G0 (2N) with con-
comitant reduction in the proportion of cells at G2/M (4N). *, p< .05. (E): Real-time monitoring of cell growth (xCelligence analysis) for
more than 100 hours following transfection with either NT or HMGB2 siRNA. (F): Immunoﬂuorescence staining revealed that HMGB2
knockdown induces loss of antigen Ki-67, a proliferation marker, in parallel with increased expression of the DNA damage mark pH2AX.
(G): HMGB2 knockdown increased SA-b-GAL activity in HESCs when compared to cells transfected with NT siRNA. Scale bar5 50 mm.
Abbreviations: HMGB2, high mobility group protein 2; NT, nontargeting; pH2AX, gamma-H2AX phosphorylation; SA-b-GAL, senescence-
associated b-galactosidase.
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sufﬁcient to reduce methylation of an informative CA-rich
locus on chromosome 6 (Supporting Information. S9). Taken
together, these observations indicate that a reduction in
HMGB2 triggers a DNA-damage response, leading to prema-
ture cycle exit and cellular senescence.
We reasoned that accelerated senescence of HESCs would
impact on the temporal changes in the decidual secretome
that coordinate early implantation events. In agreement,
knockdown of HMGB2 was sufﬁcient to compromise induction
of PRL, the cardinal decidual marker gene, in differentiating
HESCs (Fig. 5A). Induction of IGFBP1 varied greatly between
primary cultures and was compromised upon HMGB2 knock-
down, although not signiﬁcantly so (Fig. 5A). We expanded
our analysis by measuring 18 cytokines and growth factors in
the supernatants of three independent primary HESC cultures
ﬁrst transfected either NT or HMGB2 siRNA and then decid-
ualized for 2, 4, or 8 days. Partial least squares regression
analysis conﬁrmed that decidualizing HESCs mount a distinct
but transient secretory response that is most pronounced
between 2 to 4 days of differentiation (Fig. 5B). HMGB2
knockdown had little impact on the secretome of undifferenti-
ated HESCs but blunted the temporal changes in the decidual
secretome, as exempliﬁed by secretory proﬁles of vascular
endothelial growth factor (VEGF), beta nerve growth factor
(bNGF), ﬁbroblast growth factor 2 (FGF2), and interleukin 8
(IL-8) (Supporting Information Fig. S10). Thus, analysis of the
CpG methylome of HESC cultures combined with RNA-
sequencing of timed endometrial biopsies suggests that pre-
mature senescence and associated tissue inﬂammation predis-
poses for RPL.
DISCUSSION
In response to the postovulatory rise in progesterone levels, differ-
entiating HESCs transit through distinct functional phenotypes,
characterized ﬁrst by an acute proinﬂammatory phase, which is
followed by a profound anti-inﬂammatory response [11, 15]. The
initial inﬂammatory response renders the endometrium receptive
to embryo implantation, whereas acquisition of a mature secre-
tory phenotype enables the endometrium to respond to individual
embryos in a manner that either supports further development or
facilitates early rejection. RPL is associated with a blunted but pro-
longed proinﬂammatory decidual response, which in turn pro-
motes out-of-phase implantation in a hostile environment that
predisposes for miscarriage [14, 15]. This pathway is, at least
partly, recapitulated in primary HESC cultures from RPL patients
and, as shown in this study, is predicated on stem cell deﬁciency
and enhanced senescence.
Unbiased analysis of MeDIP-seq data showed that HESCs
from affected women lack a genome-wide epigenetic signa-
ture associated with pluripotent cells [29–32]. This signature,
deﬁned by DNA methylation at speciﬁc motifs in CA-rich loci,
is massively ampliﬁed in malignant peripheral nerve sheath
Figure 5. Loss of HMGB2 in HESCs perturbs decidualization. (A): HMGB2 knockdown impairs the induction of PRL and IGFBP1, cardinal
decidual marker genes, in primary cultures decidualized for the indicated time points. Data are presented as mean6 SEM, *, p< .05;
***, p< .001. (B): Two-dimensional partial least squares (PLS) loadings plot of the secretome of undifferentiated cells and cells decidual-
ized 2, 4, or 8 days following transfection with non-targeting (NT) or HMGB2 siRNA. Abbreviations: HMGB2, high mobility group protein
2; NT, nontargeting.
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tumors, presumably reﬂecting the abundance of highly aggres-
sive cancer stem cells [39, 40]. The function of non-CpG meth-
ylation in HESCs requires further investigation. In the adult
brain, CpH methylation has been implicated in gene repres-
sion whereas the opposite association was observed in embry-
onic stem cells [29, 30]. Recent studies demonstrated that
methyl-CpG binding protein 2 (MeCP2) binds to methylated
CpHs, albeit with lower afﬁnity than to methylated CpGs [29,
41]. This raises the possibility that dynamic changes in CpH
methylation regulate transcription indirectly by modulating
the spatiotemporal binding of MeCP2. Alternatively, methyla-
tion could determine access of speciﬁc transcription factors,
such as the orphan nuclear receptor TR4, to response ele-
ments embedded in CA-rich regions (Supporting Information
Table S3). The nature of the ensuing transcriptional response,
if any, is unclear as most DMRs are located away from pro-
moters in intergenic DNA and introns.
As expected, CpH but not CpG methylation in HESCs was
dependent on DNMT3A. Intriguingly, DNMT3A transcript levels
increased upon decidual transformation of HESC cultures,
which suggests that repeated waves of decidualization could
play a role in imposing or maintaining endometrial plasticity.
Induction of DNMT3A was lacking in decidualizing cultures
from RPL patients. Furthermore, analysis of timed endome-
trial biopsies showed that the level of depletion of endome-
trial stem cell populations correlates with the severity of RPL
phenotype. Lack of epigenetic stemness features in HESCs was
further associated with intragenic hypomethylation and
reduced expression of HMGB2, coding one of four members
of the HMGB family. HMGB2 is a multifaceted protein
involved in chromatin bending and DNA damage repair [42,
43]. It also functions as a major progesterone receptor coacti-
vator [44]. Furthermore, HMGB2 is implicated in maintaining
stem cell populations in adult tissues and loss of this chroma-
tin protein is a hallmark of replicative senescence of human
ﬁbroblasts [36, 45]. In HESCs, knockdown of HMGB2 was sufﬁ-
cient to block clonogenic expansion, impose cell cycle block at
G0/G1, activate the DNA damage repair pathway as evidenced
by pH2AX, and deregulate decidualization in response to
cAMP and progestin signaling. These observations in culture
are in line with transcriptome analysis of mid-luteal biopsies,
demonstrating that RPL is associated with excessive inﬂamma-
tion, heightened inﬂux of immune cells, cellular stress, and
activation of wound healing pathways.
CONCLUSIONS
As is the case for most adult tissues, resident and bone
marrow-derived MSCs are critical for endometrial homeostasis
and tissue repair [46–48]. Menstruation, miscarriage, and par-
turition impose a constant need for recruitment and activa-
tion of endometrial progenitor cells. As a consequence of
dynamic changes in stem cell populations, the endometrium
exhibits extraordinary plasticity, exempliﬁed by its seemingly
inexhaustible regenerative capacity and, presumably, its ability
to adapt following reproductive failure [6, 11, 12]. Our data
indicate that MSC deﬁciency coupled to premature senes-
cence of HESCs curtails endometrial plasticity. It is tempting
to speculate that persistence of this defect for more than sev-
eral conception cycles accounts for the consecutive nature of
miscarriages in RPL patients. This hypothesis requires further
testing in longitudinal studies to determine if endometrial
assessment in RPL patients is predictive of subsequent preg-
nancy outcome. If so, harnessing the mechanisms that control
endometrial stem cell populations may lead to effective thera-
pies to prevent RPL.
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